Clinical Trials Logo

Metastatic Thyroid Cancer clinical trials

View clinical trials related to Metastatic Thyroid Cancer.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03753919 Active, not recruiting - Clinical trials for Metastatic Thyroid Cancer

Durvalumab Plus Tremelimumab for the Treatment of Patients With Progressive, Refractory Advanced Thyroid Carcinoma -The DUTHY Trial

DUTHY
Start date: April 2, 2019
Phase: Phase 2
Study type: Interventional

This is a prospective, multi-centre, open label, stratified, exploratory phase II study evaluating the efficacy and safety of durvalumab plus tremelimumab in different cohorts of patients with thyroid cancers.